Mirae Asset Global Investments
DYN icon

Mirae Asset Global Investments’s Dyne Therapeutics DYN Stock Holding History

Mirae Asset Global Investments’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164K Sell
7,393
-1,195
-14% -$22.2K ﹤0.01% 1150
2026
Q1 		$156K Buy
8,588
+1,648
+24% +$28.4K ﹤0.01% 1107
2025
Q4 		$136K Buy
6,940
+1,440
+26% +$27.3K ﹤0.01% 1208
2025
Q3 		$69.6K Buy
5,500
+1,109
+25% +$12.6K ﹤0.01% 1293
2025
Q2 		$41.8K Buy
4,391
+606
+16% +$6.67K ﹤0.01% 1290
2025
Q1 		$43.3K Buy
3,785
+394
+12% +$5.64K ﹤0.01% 1262
2024
Q4 		$80.4K Sell
3,391
-240
-7% -$7.1K ﹤0.01% 1188
2024
Q3 		$123K Buy
3,631
+709
+24% +$28.2K ﹤0.01% 1157
2024
Q2 		$103K Sell
2,922
-25,695
-90% -$747K ﹤0.01% 1135
2024
Q1 		$540K Buy
28,617
+5,696
+25% +$129K ﹤0.01% 1863
2023
Q4 		$305K Buy
22,921
+1,199
+6% +$11.7K ﹤0.01% 2192
2023
Q3 		$195K Buy
21,722
+590
+3% +$6.36K ﹤0.01% 2312
2023
Q2 		$234K Buy
21,132
+4,042
+24% +$47.7K ﹤0.01% 2277
2023
Q1 		$197K Sell
17,090
-33
-0.2% -$429 ﹤0.01% 2336
2022
Q4 		$198K Buy
17,123
+3,172
+23% +$36.7K ﹤0.01% 2303
2022
Q3 		$177K Buy
+13,951
New +$160K ﹤0.01% 2381

Other funds holding DYN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mirae Asset Global Investments's DYN Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Dyne Therapeutics (DYN) stake by 14% in Q2 2026, selling an estimated $22.2K and leaving 7,393 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #1150.

Mirae Asset Global Investments first reported a position in DYN in Q3 2022 and has held it in 16 quarters since. The position peaked at $540K in Q1 2024. 76 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Mirae Asset Global Investments held 7,393 shares of Dyne Therapeutics worth $164K as of Q2 2026.
  • Mirae Asset Global Investments sold 1,195 Dyne Therapeutics shares in Q2 2026, an estimated $22.2K.
  • Dyne Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1150 holding.
  • Mirae Asset Global Investments first reported a position in Dyne Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • Mirae Asset Global Investments's Dyne Therapeutics position peaked at $540K in Q1 2024.
  • 76 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.